Cushing Syndrome Caused by Adrenocortical Tumors and Hyperplasias (Corticotropin- Independent Cushing Syndrome)
- 1 January 2008
- book chapter
- Published by S. Karger AG
- Vol. 13, 117-132
- https://doi.org/10.1159/000134829
Abstract
Endogenous Cushing syndrome (CS) is caused by excess adrenal glucocorticoid secretion that is adrenocorticotropin (ACTH)-dependent or independent; ACTH-independent adrenocortical causes of CS account for up to 20% of CS in adults, and 15% in children over age 7 years. In younger children, ACTH-independent CS may account for as many as half of the CS cases. In both adults and children, adrenocortical lesions causing CS include the common, isolated and sporadic, solitary cortisol-producing adenoma, the rare adrenocortical cancer, and a spectrum of recently recognized, bilateral hyperplasias (bilateral adrenocortical hyperplasias, BAHs): micronodular adrenal disease and its pigmented variant, primary pigmented nodular adrenocortical disease are mostly genetic processes. Macronodular BAHs, ACTH-independent macronodular hyperplasia or massive macronodular adrenocortical disease are less frequently genetic and almost never present in children (except in McCune-Albright syndrome); they present often with atypical CS in middle-aged or elderly adults. The majority of benign adrenocortical tumors associated with CS are associated with defects of the cAMP signaling pathway, whereas adrenal cancer is linked to aberrant expression of growth factors and germline or somatic mutations of tumor suppressor genes such as TP53. Adrenalectomy is the preferred mode of treatment for all adrenocortical causes of CS.Keywords
This publication has 33 references indexed in Scilit:
- Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasiasNature Clinical Practice Endocrinology & Metabolism, 2007
- Adrenocortical cancer: pathophysiology and clinical managementEndocrine-Related Cancer, 2007
- Adrenal Hyperplasia and Adenomas Are Associated with Inhibition of Phosphodiesterase 11A in Carriers of PDE11A Sequence Variants That Are Frequent in the PopulationCancer Research, 2006
- Management of the Clinically Inapparent Adrenal Mass (“Incidentaloma”)Annals of Internal Medicine, 2003
- An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinomaProceedings of the National Academy of Sciences, 2001
- Cushing's syndromeThe Lancet, 2001
- Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complexNature Genetics, 2000
- The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s StatesEndocrine Reviews, 1998
- Hyperplastic and tumorous lesions of the adrenals in an unselected autopsy seriesEndocrine Pathology, 1998
- Clinical and Genetic Analysis of Primary Bilateral Adrenal Diseases (Micro- and Macronodular Disease) Leading to Cushing SyndromeHormone and Metabolic Research, 1998